Home
Scholarly Works
408 A phase II study of erlotinib in combination...
Journal article

408 A phase II study of erlotinib in combination with cisplatin in patients with recurrent or metastatic squamous cell cancer of the head and neck (PHL-002e/NCIC CTG IND.157)

Authors

Winquist E; Soulieres D; Chen E; Tsao M; Klein M; Pond G; Dancey J; Eisenhauer E; Siu LL

Journal

European Journal of Cancer Supplements, Vol. 2, No. 8,

Publisher

Elsevier

Publication Date

September 1, 2004

DOI

10.1016/s1359-6349(04)80415-4

ISSN

1359-6349

Contact the Experts team